AbbVie Inc. (NYSE:ABBV) revealed topline results from its pivotal Phase 3 TEMPO-2 trial, which evaluated investigational ...
AbbVie (ABBV) announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody ...
AbbVie (ABBV) announced positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating investigational tavapadon as a flexible-dose ...
The suspect apparently gave a four-star review to the book form of the lengthy manifesto ...
Netflix has revealed some more first looks and a new English-language name for its new Italian action drama series, Public Disorder. It was previously developed under the name A.C.A.B. La Series, ...